#United States #San Antonio #Journavx #Non-Opioid #Gary Lawton

Transforming Pain Management in Cosmetic Surgery

In the ever-evolving landscape of cosmetic surgery, Dr. Gary Lawton stands at the forefront with over 25 years of experience. Based in San Antonio, Texas, he has performed tens of thousands of surgeries, primarily focused on breast and body procedures. Acknowledging the persistent concern of postoperative pain, Dr. Lawton has recently introduced JOURNAVX® (suzetrigine), a groundbreaking, non-opioid medication approved by the U.S. FDA, into his recovery protocols.

Understanding JOURNAVX®

JOURNAVX® represents a significant advancement in pain management, particularly for patients undergoing surgeries such as breast augmentation, tummy tucks, and liposuction. This medication selectively targets NaV1.8 sodium channels responsible for pain signaling in the peripheral nervous system, offering an innovative approach without activating traditional opioid receptors. Approved in January 2025, it addresses the critical need for alternatives to narcotics in managing moderate to severe postoperative pain.

Evolution of Pain Management Strategies

Dr. Lawton has devoted his career to refining surgical and recovery techniques, assessing every new development in postoperative care. He notes that while many improvements have been incremental, the integration of JOURNAVX® marks a paradigm shift. "It is not just about comfort; it is about advancing how we manage pain for complex procedures like tummy tucks and mommy makeovers, where recovery discomfort is a common concern for patients," he states.

When incorporated into his comprehensive multimodal recovery protocol, patients have reported significantly less reliance on narcotics, experiencing enhanced comfort levels post-surgery.

Patient Experience and Outcomes

Feedback from patients has been overwhelmingly positive. Many express surprise at the level of comfort they experience, noting, "I felt less pain after surgery than I expected." According to Dr. Lawton, this reduction in opioid consumption is critical not only for individual patient outcomes but also in the larger context of opioid stewardship in medicine.

At Lawton Plastic Surgery, where high-volume procedures are the norm, Dr. Lawton emphasizes the importance of real-world data in shaping future recovery protocols. He envisions a landscape where non-opioid therapies become central to postoperative care across all cosmetic procedures, enhancing patient comfort and reducing complications associated with opioid use.

Looking Ahead

Dr. Lawton is committed to continuing this evaluation, planning to track patient-reported outcomes and recovery milestones as more patients participate in the updated protocol. His goal is to demonstrate how JOURNAVX® can facilitate smoother recoveries, not only enhancing patient satisfaction but also potentially reshaping conventional recovery paradigms in cosmetic surgery.

As more surgeons adopt innovative solutions like JOURNAVX®, the future of postoperative recovery in the cosmetic field looks promising. Patients can expect a more comfortable journey through their aesthetic transformations, reflecting a broader commitment to safety and efficacy in medical practices.

In conclusion, Dr. Gary Lawton's integration of JOURNAVX® into his recovery protocols signifies a crucial evolution in pain management for cosmetic surgery patients, ensuring that comfort and safety remain paramount.

About Dr. Gary Lawton

Dr. Gary Lawton is a Yale-trained, board-certified cosmetic plastic surgeon recognized for excellence in breast and body surgery. His practice is dedicated to continuous improvement, focused on patient outcomes and innovative recovery methodologies.